2.08
price down icon2.02%   -0.12
 
loading
Schlusskurs vom Vortag:
$2.20
Offen:
$2.1
24-Stunden-Volumen:
10,418
Relative Volume:
0.48
Marktkapitalisierung:
$6.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.8254
EPS:
-2.52
Netto-Cashflow:
$-6.25M
1W Leistung:
-2.02%
1M Leistung:
-43.62%
6M Leistung:
-52.62%
1J Leistung:
-23.01%
1-Tages-Spanne:
Value
$2.05
$2.161
1-Wochen-Bereich:
Value
$2.05
$2.32
52-Wochen-Spanne:
Value
$2.05
$6.46

Edesa Biotech Inc Stock (EDSA) Company Profile

Name
Firmenname
Edesa Biotech Inc
Name
Telefon
(905) 475-1234
Name
Adresse
100 SPY COURT, MARKHAM, ON
Name
Mitarbeiter
16
Name
Twitter
@EdesaBiotech
Name
Nächster Verdiensttermin
2024-08-12
Name
Neueste SEC-Einreichungen
Name
EDSA's Discussions on Twitter

Vergleichen Sie EDSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
EDSA 2.06 6.79M 0 -7.72M -6.25M -2.52
VRTX 450.44 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.43 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.53 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.84 24.89B 3.30B -501.07M 1.03B 11.54

Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten

pulisher
Nov 20, 2024

EDSA stock touches 52-week low at $2.08 amid market challenges By Investing.com - Investing.com South Africa

Nov 20, 2024
pulisher
Nov 20, 2024

EDSA stock touches 52-week low at $2.08 amid market challenges - Investing.com

Nov 20, 2024
pulisher
Nov 13, 2024

EDSA stock touches 52-week low at $2.27 amid market challenges - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

500: Something went wrong - Investing.com

Nov 13, 2024
pulisher
Oct 31, 2024

Edesa Leaps as CEO Boosts Holdings - Baystreet.ca

Oct 31, 2024
pulisher
Oct 31, 2024

Edesa Biotech CEO invests $5 million in company By Investing.com - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Edesa Biotech’s Founder Makes Strategic Investment in the Company - GlobeNewswire

Oct 31, 2024
pulisher
Oct 21, 2024

Edesa Biotech to Present at Global Conferences - Nasdaq

Oct 21, 2024
pulisher
Oct 21, 2024

Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewswire

Oct 21, 2024
pulisher
Oct 04, 2024

Edesa Biotech Partners with Wainwright for Share Sales - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Edesa Biotech (EDSA) Price Target Increased by 528.00% to 53.38 - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today? - MSN

Oct 04, 2024
pulisher
Sep 25, 2024

Edesa Biotech (NASDAQ:EDSA) Shares Down 1.6% - Defense World

Sep 25, 2024
pulisher
Sep 13, 2024

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc. - GlobeNewswire Inc.

Sep 13, 2024
pulisher
Sep 13, 2024

S&P Smallcap 600 (IQY) QuotePress Release - The Globe and Mail

Sep 13, 2024
pulisher
Sep 13, 2024

1 Dividend Stock to Invest in the Domestic Steel Market Now - The Globe and Mail

Sep 13, 2024
pulisher
Sep 10, 2024

Celsius Holdings Inc (CELH-Q) QuotePress Release - The Globe and Mail

Sep 10, 2024
pulisher
Sep 09, 2024

Mackenzie Investments Announces Results of Special Meetings on Mutual Fund and ETF Mergers - Yahoo Canada Finance

Sep 09, 2024
pulisher
Sep 06, 2024

ECB interest rate cut likely as Eurozone economy weaker than expected - Yahoo Finance UK

Sep 06, 2024
pulisher
Aug 29, 2024

Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions - Yahoo Finance UK

Aug 29, 2024
pulisher
Aug 27, 2024

Santander starts $1.7 billion share buyback programme - Yahoo Finance UK

Aug 27, 2024
pulisher
Aug 22, 2024

FY2024 Earnings Estimate for Edesa Biotech, Inc. (NASDAQ:EDSA) Issued By HC Wainwright - Defense World

Aug 22, 2024
pulisher
Aug 20, 2024

H.C. Wainwright bullish on Edesa Biotech stock amid BARDA study support - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Edesa Biotech’s (EDSA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Aug 20, 2024
pulisher
Aug 20, 2024

EDSA: EB05 Selected for BARDA-Funded Study in ARDS… - Zacks Small Cap Research

Aug 20, 2024
pulisher
Aug 09, 2024

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results - GlobeNewswire

Aug 09, 2024
pulisher
Aug 08, 2024

Edesa Biotech (NASDAQ:EDSA) Stock Price Down 2% - Defense World

Aug 08, 2024
pulisher
Aug 06, 2024

Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - XM

Aug 06, 2024
pulisher
Jul 29, 2024

Ethiopian Airlines posts 14% jump in full-year revenue - Yahoo Finance UK

Jul 29, 2024
pulisher
Jul 25, 2024

Alexis Shamess | Corporate/Commercial Lawyer in Toronto | People - Fasken

Jul 25, 2024
pulisher
Jul 24, 2024

Myroslav Chwaluk | Mergers & Acquisitions Lawyer in Toronto | People - Fasken

Jul 24, 2024
pulisher
Jul 24, 2024

A. Wojtek BaraniakPolish-speaking Corporate/Commercial lawyer in Toronto | People - Fasken

Jul 24, 2024
pulisher
Jul 17, 2024

MoneySmart’s June Lucky Draw 2024 - Yahoo Finance

Jul 17, 2024
pulisher
Jul 11, 2024

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential - Yahoo Finance UK

Jul 11, 2024
pulisher
Jul 09, 2024

Homebuilder Vistry boosts output target as cost inflation softens - Yahoo Finance UK

Jul 09, 2024
pulisher
Jul 04, 2024

German environmental authorities approve Tesla site expansion - Yahoo Finance UK

Jul 04, 2024
pulisher
Jun 30, 2024

Cipher Pharmaceuticals - The Pharma Letter

Jun 30, 2024
pulisher
Jun 29, 2024

Edesa Biotech (NASDAQ:EDSA) Receives Buy Rating from HC Wainwright - Defense World

Jun 29, 2024
pulisher
Jun 28, 2024

Allied gaming executive Choi buys shares worth $778k By Investing.com - Investing.com

Jun 28, 2024
pulisher
Jun 24, 2024

Bioventus exec sells over $14k in company stock By Investing.com - Investing.com

Jun 24, 2024
pulisher
Jun 24, 2024

Edesa's Paridiprubart Selected for U.S.-Funded Platform Trial in General ARDS - Contract Pharma

Jun 24, 2024
pulisher
Jun 24, 2024

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS - StockTitan

Jun 24, 2024
pulisher
Jun 24, 2024

Edesa’s Paridiprubart Selected For U.S.-Funded Platform Trial In General ARDS - Contract Pharma

Jun 24, 2024
pulisher
Jun 16, 2024

Comparing Assertio (NASDAQ:ASRT) and Edesa Biotech (NASDAQ:EDSA) - Defense World

Jun 16, 2024
pulisher
Jun 15, 2024

Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Rises By 32.1% - Defense World

Jun 15, 2024
pulisher
Jun 15, 2024

Perritt Capital Management Inc. Has $482000 Stake in Usio, Inc. (NASDAQ:USIO) - Defense World

Jun 15, 2024
pulisher
Jun 14, 2024

Anixa Biosciences director buys shares worth over $1,000 By Investing.com - Investing.com

Jun 14, 2024
pulisher
Jun 10, 2024

Stephens Inc. AR Has $1.30 Million Stock Holdings in DuPont de Nemours, Inc. (NYSE:DD) - Defense World

Jun 10, 2024
pulisher
Jun 06, 2024

French jet engine maker Safran gets Italy's clearance to buy Microtecnica - Yahoo Finance UK

Jun 06, 2024
pulisher
May 30, 2024

Edesa Biotech Shareholders Approve Board and Compensation PlansTipRanks.com - TipRanks

May 30, 2024
pulisher
May 30, 2024

Edesa Biotech, Inc. Forecasted to Earn FY2024 Earnings of ($1.95) Per Share (NASDAQ:EDSA) - Defense World

May 30, 2024

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):